Novel delivery approaches for cancer therapeutics

J Control Release. 2015 Dec 10:219:248-268. doi: 10.1016/j.jconrel.2015.09.067. Epub 2015 Oct 9.

Abstract

Currently, a majority of cancer treatment strategies are based on the removal of tumor mass mainly by surgery. Chemical and physical treatments such as chemo- and radiotherapies have also made a major contribution in inhibiting rapid growth of malignant cells. Furthermore, these approaches are often combined to enhance therapeutic indices. It is widely known that surgery, chemo- and radiotherapy also inhibit normal cells growth. In addition, these treatment modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This review encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Currently, cancer treatment is a highly dynamic field and significant advances are being made in the development of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, triggered release, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have added new modalities for cancer treatment. These approaches have led to selective detection of malignant cells leading to their eradication with minimal side effects. Lowering multi-drug resistance and involving influx transportation in targeted drug delivery to cancer cells can also contribute significantly in the therapeutic interventions in cancer.

Keywords: Cancer; Cell Penetrating Peptides; Chemotherapeutics; Efflux Pumps; Gene therapy; Immunotherapy; Stem cells; Targeted Drug Delivery; Tumor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use
  • Drug Delivery Systems*
  • Drug Resistance, Neoplasm
  • Humans
  • Immunotherapy
  • Molecular Targeted Therapy*
  • Nanoparticles / administration & dosage
  • Nanoparticles / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / therapy
  • Prodrugs / therapeutic use

Substances

  • Antineoplastic Agents
  • Prodrugs